Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about SUPEROXIDE: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
| Name | SUPEROXIDE |
| Related Diseases | AMYOTROPHIC LATERAL SCLEROSIS, AUTOPHAGY, DOPAMINE, ISCHEMIA, OXIDATIVE STRESS |
| Related Pathways | NLRP3 INFLAMMASOME, NRF2 PATHWAY |
graph TD
SUPEROXIDE[SUPEROXIDE]
SUPEROXIDE -->|modulates| Vascular_Remodelling[Vascular Remodelling]
SUPEROXIDE -->|activates| NFE2L2[NFE2L2]
SUPEROXIDE -->|activates| DOPAMINE[DOPAMINE]
SUPEROXIDE -->|inhibits| OXIDATIVE_STRESS[OXIDATIVE STRESS]
SUPEROXIDE -->|regulates| ROS[ROS]
ROS -->|interacts| SUPEROXIDE
CEREBELLUM[CEREBELLUM] -->|causes| SUPEROXIDE
HIPPOCAMPUS[HIPPOCAMPUS] -->|treats| SUPEROXIDE
ISCHEMIA[ISCHEMIA] -->|activates| SUPEROXIDE
NEURONS[NEURONS] -->|causes| SUPEROXIDE
OXIDATIVE_STRESS -->|encodes| SUPEROXIDE
AUTOPHAGY[AUTOPHAGY] -->|expressed in| SUPEROXIDE| Target | Relation | Type | Str |
|---|---|---|---|
| NFE2L2 | activates | gene | 0.85 |
| Vascular Remodelling | modulates | process | 0.85 |
| DOPAMINE | activates | phenotype | 0.65 |
| ROS | inhibits | phenotype | 0.65 |
| ROS | regulates | phenotype | 0.65 |
| OXIDATIVE STRESS | inhibits | phenotype | 0.65 |
| BRAINSTEM | associated_with | brain_region | 0.45 |
| CORTEX | associated_with | brain_region | 0.45 |
| RAPAMYCIN | associated_with | drug | 0.45 |
| Source | Relation | Type | Str |
|---|---|---|---|
| NEURONS | regulates | cell_type | 0.65 |
| OXIDATIVE STRESS | encodes | phenotype | 0.65 |
| NEURONS | causes | cell_type | 0.65 |
| ISCHEMIA | regulates | disease | 0.65 |
| ISCHEMIA | activates | disease | 0.65 |
| CEREBELLUM | causes | brain_region | 0.65 |
| ROS | interacts_with | phenotype | 0.65 |
| HIPPOCAMPUS | treats | brain_region | 0.65 |
| AUTOPHAGY | expressed_in | phenotype | 0.55 |
| NEURONS | participates_in | cell_type | 0.55 |
| SPINAL CORD | associated_with | brain_region | 0.45 |
| NLRP3 INFLAMMASOME | associated_with | pathway | 0.45 |
| CEREBELLUM | associated_with | brain_region | 0.45 |
| HIPPOCAMPUS | associated_with | brain_region | 0.45 |
| EMPAGLIFLOZIN | associated_with | drug | 0.45 |
| NRF2 PATHWAY | associated_with | pathway | 0.45 |
| DAPAGLIFLOZIN | associated_with | drug | 0.45 |
| AMYOTROPHIC LATERAL SCLEROSIS | associated_with | disease | 0.45 |
| SUBSTANTIA NIGRA | associated_with | brain_region | 0.45 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning SUPEROXIDE in their description or question text
No additional research found